83P Association of lung immune prognostic index (LIPI) with progression-free survival (PFS) in soft-tissue sarcoma (STS) patients treated with immunotherapy (IO) in early phase trials — Elise F. Nassif (2021) | RDL Network
83P Association of lung immune prognostic index (LIPI) with progression-free survival (PFS) in soft-tissue sarcoma (STS) patients treated with immunotherapy (IO) in early phase trials
Marianne Zoghbi, Bharti Patel, Matthieu Roulleaux Dugage, Laura Mezquita, Rastilav Bahleda, Armelle Dufresne, Mehdi Brahmi, Isabelle Ray‐Coquard, Patricia Pautier, Jean Yves Blay, Axel Le Cesne, Christophe Massard, Benjamin Besse, Édouard Auclin, Elise F. Nassif
Javier Martín‐Broto, David S. Moura, Rafael Ramos, Luca Braglia, Paola Collini, Salvatore Lorenzo Renne, Cleofé Romagosa, Jean Michel Coindre, Valérie Velasco, Domenico Franco Merlo, Emanuela Palmerini, Silvia Stacchiotti, Vittorio Quagliuolo, Antonio López–Pousa, Giovanni Grignani, Jean Yves Blay, Antonella Brunello, Piero Picci, Paolo G. Casali, Alessandro Gronchi
Silvia Stacchiotti, Carlo Morosi, Luca Braglia, Emanuela Palmerini, Vittorio Quagliuolo, Javier Martín‐Broto, Antonio López–Pousa, Giovanni Grignani, Antonella Brunello, Jean Yves Blay, Oscar Tendero, Robert Díaz Beveridge, Iwona Ługowska, Valeria Fontana, Emanuela Marchesi, Elena Palassini, Paolo Bruzzi, Domenico Franco Merlo, Paolo G. Casali, Alessandro Gronchi
Elise F. Nassif, Jean Yves Blay, Rastislav Bahleda, Armelle Dufresne, B. Mehdi, Isabelle Laure Ray-Coquard, Patricia Pautier, Alexandra Léary, Antonin Lévy, C. Le Péchoux, Charles Honoré, Olivier Mir, Christophe Massard, Axel Le Cesne
Anna Maria Frezza, Silvia Stacchiotti, Frédéric Chibon, Jean‐Michelle Coindre, Antoîne Italiano, Cleofe Romagnosa, Sílvia Bagué, Angelo Paolo Dei Tos, Luca Braglia, Emanuela Palmerini, Vittorio Quagliuolo, Javier Martín‐Broto, Antonio López–Pousa, Giovanni Grignani, Antonella Brunello, Jean Yves Blay, Robert Díaz Beveridge, Iwona Ługowska, Tom Lesluyes, Roberta Maestro, Domenico Franco Merlo, Paolo G. Casali,
Discussion(0)
No comments yet. Be the first to comment.